Welcome to our dedicated page for KONINKLIJKE AD N.V. S/ADR news (Ticker: ADRNY), a resource for investors and traders seeking the latest updates and insights on KONINKLIJKE AD N.V. S/ADR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect KONINKLIJKE AD N.V. S/ADR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of KONINKLIJKE AD N.V. S/ADR's position in the market.
Ahold Delhaize reported Q2 2021 net sales of €18.6 billion, a 3.0% increase at constant exchange rates, but down 2.4% at actual rates. Comparable sales in the U.S. fell 1.5%, while Europe saw a 2.4% growth. Online sales surged 35.8%, reflecting strong growth trends. Despite rising underlying EPS guidance for 2021, the interim dividend is reduced to €0.43 from €0.50 in 2020. The company anticipates a high-teen growth in underlying EPS compared to 2019. Underlying operating margin projected at 4.3%. Overall, the outlook remains cautious amidst ongoing COVID-19 challenges.
FAQ
What is the current stock price of KONINKLIJKE AD N.V. S/ADR (ADRNY)?
What is the market cap of KONINKLIJKE AD N.V. S/ADR (ADRNY)?
